Jinhua He

Mrs. Jinhua He


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2023 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
WLWenfeng Luo
Wenfeng Luo
JDJie Deng
Jie Deng
JHJiecheng He
Jiecheng He
LYLiang Yin
Liang Yin
RYRong You
Rong You
YGYan-Qin Guan
Yan-Qin Guan
Fenugreek is an ancient herb that has been used for centuries to treat diabetes. However, how the fenugreek‐derived chemical compounds work in treating diabetes remains unclarified. Herein, we integrate molecular docking and network pharmacology to elucidate the active constituents and potential mechanisms of fenugreek against diabetes. First, 19 active compounds from fenugreek and 71 key diabetes‐related targets were identified through network pharmacology analysis. Then, molecular docking and simulations results suggest diosgenin, luteolin and quercetin against diabetes via regulation of the genes ESR1, CAV1, VEGFA, TP53, CAT, AKT1, IL6 and IL1. These compounds and genes may be key factors of fenugreek in treating diabetes. Cells results demonstrate that fenugreek has good biological safety and can effectively improve the glucose consumption of IR‐HepG2 cells. Pathway enrichment analysis revealed that the anti‐diabetic effect of fenugreek was regulated by the AGE‐RAGE and NF‐κB signalling pathways. It is mainly associated with anti‐oxidative stress, anti‐inflammatory response and β‐cell protection. Our study identified the active constituents and potential signalling pathways involved in the anti‐diabetic effect of fenugreek. These findings provide a theoretical basis for understanding the mechanism of the anti‐diabetic effect of fenugreek. Finally, this study may help for developing anti‐diabetic dietary supplements or drugs based on fenugreek.

29 September 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ZHZeping Han
Zeping Han
JLJiening Liang
Jiening Liang
YLYuguang Li
Yuguang Li
JHJinhua He
Jinhua He
B-cell lymphoma 2 (Bcl-2) is a regulator protein involved in apoptosis. In the past few decades, this protein has been demonstrated to have high efficacy in cancer therapy, and several approaches targeting Bcl-2 have been tested clinically (e.g., oblimersen, ABT-737, ABT-263, obatoclax mesylate, and AT-101). This review reports potential Bcl-2 inhibitors according to current information on their underlying mechanism and the results of clinical trials. In addition, the function and mechanisms of other potentially valuable Bcl-2 inhibitors that did not show efficacy in clinical studies are also discussed. This summary of the development of Bcl-2 inhibitors provides worthwhile viewpoints on the use of biomedical approaches in future cancer therapy.

28 April 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
ZHZeping Han
Zeping Han
HCHuafang Chen
Huafang Chen
ZGZhonghui Guo
Zhonghui Guo
JSJian Shen
Jian Shen
WLWenfeng Luo
Wenfeng Luo
JHJinhua He
Jinhua He
As a novel class of endogenous non-coding RNAs discovered in recent years, circular RNAs (circRNAs) are highly conserved and stable covalently closed ring structures with no 5′-end cap or 3′-end poly(A) tail. CircRNAs are formed by reverse splicing, mainly by means of a noose structure or intron complementary pairing. Exosomes are tiny discoid vesicles with a diameter of 40-100 nm that are secreted by cells under physiological and pathological conditions. Exosomes play an important role in cell-cell communication by carrying DNA, microRNAs, mRNAs, proteins and circRNAs. In this review, we summarize the biological functions of circRNAs and exosomes, and further reveal the potential roles of exosomal circRNAs in different diseases, providing a scientific basis for the diagnosis, treatment, and prognosis of a wide variety of diseases.

6 May 2024 in Clinical Immunology
Verified
Journal Article
Closed access
JLJiabin Liang
Jiabin Liang
ZHZeping Han
Zeping Han
JFJie Feng
Jie Feng
FXFangmei Xie
Fangmei Xie
WLWenfeng Luo
Wenfeng Luo
JHJinhua He
Jinhua He

1 January 2023 in Journal of Cancer
Verified
Journal Article
Open access
PDF file
CGChenqiong Gu
Chenqiong Gu
LTLin Dong Tang
Lin Dong Tang
YHYinghui Hao
Yinghui Hao
SDShanshan Dong
Shanshan Dong
JSJian Shen
Jian Shen
LYLi Yu
Li Yu
Purpose: CRC is a malignant tumor seriously threatening human health. Quercetin and kaempferol are representative components of traditional Chinese medicine (TCM). Previous studies have shown that both quercetin and kaempferol have antitumor pharmacological effects, nevertheless, the underlying mechanism of action remains unclear. To explore the synergy and mechanism of quercetin and kaempferol in colorectal cancer.

24 February 2024 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
YHYinghui Hao
Yinghui Hao
FXFangmei Xie
Fangmei Xie
JHJieyi He
Jieyi He
CGChenqiong Gu
Chenqiong Gu
YZYing Zhao
Ying Zhao
JHJinhua He
Jinhua He